These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
690 related items for PubMed ID: 30675881
21. Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats. Tan Y, Kim J, Cheng J, Ong M, Lao WG, Jin XL, Lin YG, Xiao L, Zhu XQ, Qu XQ. World J Gastroenterol; 2017 Jun 07; 23(21):3805-3814. PubMed ID: 28638220 [Abstract] [Full Text] [Related]
22. Diosgenin ameliorates palmitic acid-induced lipid accumulation via AMPK/ACC/CPT-1A and SREBP-1c/FAS signaling pathways in LO2 cells. Fang K, Wu F, Chen G, Dong H, Li J, Zhao Y, Xu L, Zou X, Lu F. BMC Complement Altern Med; 2019 Sep 13; 19(1):255. PubMed ID: 31519174 [Abstract] [Full Text] [Related]
23. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease. Fu D, Cui H, Zhang Y. Cell Physiol Biochem; 2018 Sep 13; 45(6):2187-2198. PubMed ID: 29550812 [Abstract] [Full Text] [Related]
24. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis. Yin X, Liu Z, Wang J. Phytomedicine; 2023 Oct 13; 119():155005. PubMed ID: 37562090 [Abstract] [Full Text] [Related]
25. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells. Zeng L, Tang W, Yin J, Feng L, Li Y, Yao X, Zhou B. Cell Physiol Biochem; 2016 Oct 13; 40(3-4):453-464. PubMed ID: 27889747 [Abstract] [Full Text] [Related]
26. 5,7-Dimethoxyflavone Attenuates Obesity by Inhibiting Adipogenesis in 3T3-L1 Adipocytes and High-Fat Diet-Induced Obese C57BL/6J Mice. Song Y, Kim MB, Kim C, Kim J, Hwang JK. J Med Food; 2016 Dec 13; 19(12):1111-1119. PubMed ID: 27828718 [Abstract] [Full Text] [Related]
27. Ginsenoside Re lowers blood glucose and lipid levels via activation of AMP-activated protein kinase in HepG2 cells and high-fat diet fed mice. Quan HY, Yuan HD, Jung MS, Ko SK, Park YG, Chung SH. Int J Mol Med; 2012 Jan 13; 29(1):73-80. PubMed ID: 21971952 [Abstract] [Full Text] [Related]
33. The role of hepassocin in the development of non-alcoholic fatty liver disease. Wu HT, Lu FH, Ou HY, Su YC, Hung HC, Wu JS, Yang YC, Wu CL, Chang CJ. J Hepatol; 2013 Nov 13; 59(5):1065-72. PubMed ID: 23792031 [Abstract] [Full Text] [Related]
34. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice. Luo L, Fang K, Dan X, Gu M. Lipids Health Dis; 2019 Jan 08; 18(1):11. PubMed ID: 30621686 [Abstract] [Full Text] [Related]
35. Effects of the new thiazolidine derivative LPSF/GQ-02 on hepatic lipid metabolism pathways in non-alcoholic fatty liver disease (NAFLD). Araújo S, Soares E Silva A, Gomes F, Ribeiro E, Oliveira W, Oliveira A, Lima I, Lima MDC, Pitta I, Peixoto C. Eur J Pharmacol; 2016 Oct 05; 788():306-314. PubMed ID: 27349145 [Abstract] [Full Text] [Related]
37. Hovenia Dulcis Extract Reduces Lipid Accumulation in Oleic Acid-Induced Steatosis of Hep G2 Cells via Activation of AMPK and PPARα/CPT-1 Pathway and in Acute Hyperlipidemia Mouse Model. Kim B, Woo MJ, Park CS, Lee SH, Kim JS, Kim B, An S, Kim SH. Phytother Res; 2017 Jan 05; 31(1):132-139. PubMed ID: 27762456 [Abstract] [Full Text] [Related]
38. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation. Castaño D, Larequi E, Belza I, Astudillo AM, Martínez-Ansó E, Balsinde J, Argemi J, Aragon T, Moreno-Aliaga MJ, Muntane J, Prieto J, Bustos M. J Hepatol; 2014 May 05; 60(5):1017-25. PubMed ID: 24362075 [Abstract] [Full Text] [Related]
39. Coenzyme Q10 increases the fatty acid oxidation through AMPK-mediated PPARα induction in 3T3-L1 preadipocytes. Lee SK, Lee JO, Kim JH, Kim N, You GY, Moon JW, Sha J, Kim SJ, Lee YW, Kang HJ, Park SH, Kim HS. Cell Signal; 2012 Dec 05; 24(12):2329-36. PubMed ID: 22885103 [Abstract] [Full Text] [Related]
40. Antrodia cinnamomea Prevents Obesity, Dyslipidemia, and the Derived Fatty Liver via Regulating AMPK and SREBP Signaling. Peng CH, Yang MY, Yang YS, Yu CC, Wang CJ. Am J Chin Med; 2017 Dec 05; 45(1):67-83. PubMed ID: 28161992 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]